Hence, these data suggest that BCR-ABL induced–enhanced expression of HIF-1α in CML cells, including CML-LSCs, may contribute to their quiescence and survival in the hypoxic endosteal niche of HSCs in BM after treatment initiation and disease relapse. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.